PROKIDNEY CORP. - Ordinary Shares (PROK)

Historical Holders from Q2 2022 to Q3 2025

Symbol
PROK on Nasdaq
Type / Class
Equity / Ordinary Shares
Underlying class
Class A Ordinary Shares
Shares outstanding
129,821,091
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
1,000,917
Holdings value
$2,422,308
% of all portfolios
0%
Number of holders
4
Number of buys
1
Number of sells
-48
Average buys %
0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of PROKIDNEY CORP. - Ordinary Shares (PROK)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Tolerantia, LLC 36.5% -3.9% $93,004,165 -$3,326,877 106,901,339 -3.5% Tolerantia, LLC 03 Jun 2025
MORGAN STANLEY 4.4% -42% $3,370,156 -$2,564,610 5,712,128 -43% Morgan Stanley 30 Jun 2025
BlackRock, Inc. 1.4% $1,182,283 1,764,602 BlackRock, Inc. 30 Jun 2025

Institutional Holders of PROKIDNEY CORP. - Ordinary Shares (PROK)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 1,000,917 $2,422,308 -$19,991,585 $2.42 4
2025 Q2 34,704,784 $20,548,205 -$8,230,826 $0.5921 50
2025 Q1 47,997,221 $42,032,793 -$2,665,006 $0.8762 68
2024 Q4 50,919,833 $86,053,287 +$2,729,891 $1.69 72
2024 Q3 49,144,737 $94,328,129 +$11,886,322 $1.92 69
2024 Q2 40,154,003 $98,780,645 +$33,020,412 $2.46 63
2024 Q1 26,784,444 $43,927,164 -$4,143,589 $1.64 52
2023 Q4 29,378,261 $52,277,921 -$53,744,159 $1.78 61
2023 Q3 40,416,757 $185,108,424 +$2,228,153 $4.58 64
2023 Q2 39,818,774 $445,584,614 +$58,753,645 $11.19 56
2023 Q1 34,565,347 $391,195,593 +$35,473,985 $11.32 35
2022 Q4 31,432,933 $215,647,663 +$14,576,098 $6.86 27
2022 Q3 16,024,777 $144,383,000 +$137,048,999 $9.01 16
2022 Q2 736,968 $7,334,000 +$7,334,000 $9.95 1